+308.9%
MSTR vs EMR
+63.1%
+245.8%
-82.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.4% | +1.7% | -3.1% | -2.9% |
| 7D | +12.2% | -1.5% | +13.7% | +13.7% |
| 30D | +45.2% | -5.6% | +50.8% | +52.1% |
| 3M | +10.4% | +7.9% | +2.4% | +1.7% |
| 6M | -2.5% | +6.0% | -8.5% | -9.2% |
| YTD | -6.0% | +16.4% | -22.5% | -19.8% |
| 1Y | -56.4% | +16.6% | -73.0% | -63.2% |
| All | +308.9% | +63.1% | +245.8% | +188.4% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling